MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Servotronics (NYSE American: SVT) for possible breaches of fiduciary duty and other violations of law in its transaction with TransDigm.
MILWAUKEE, May 27, 2026 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against Zscaler (NASDAQ: ZS). The investigation results from inaccurate statements Zscaler may have ...
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating E2open (NYSE: ETWO) for possible breaches of fiduciary duty and other violations of law in its transaction with WiseTech. Click here to ...
Shareholder Alert: The Ademi Firm Continues to Investigate Whether Sapiens International Corporation Is Obtaining a Fair Price for Its Public Shareholders The Ademi Firm is investigating Sapiens ...
MILWAUKEE, Dec. 30, 2025 /PRNewswire/ -- The Ademi Firm is investigating ON24 (NYSE: ONTF) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction ...
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Aerovate (Nasdaq: AVTE) for possible breaches of fiduciary duty and other violations of law in its transaction with Jade. Click here to learn how ...
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating TEGNA (NYSE: TEGNA) for possible breaches of fiduciary duty and other violations of law in its going-private transaction. Click here to ...
MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Duckhorn (NYSE: NAPA) for possible breaches of fiduciary duty and other violations of law in its transaction with Butterfly Equity. Click here to ...
MILWAUKEE, March 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Day One (NASDAQ: DAWN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction ...
MILWAUKEE, March 9, 2026 /PRNewswire/ -- Ademi LLP is investigating Talkspace (NASDAQ: TALK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction ...
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Inozyme (Nasdaq: INZY) for possible breaches of fiduciary duty and other violations of law in its transaction with BioMarin. Click here to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results